Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

View:
Post by inthno on Nov 26, 2024 12:03am

Irene

The Irene trial did not meet the clinical endpoints and the trial was terminated after stage 1 so not much more to say about that. Let's hope Roche still steps up
Comment by canadafan on Nov 26, 2024 11:58am
Clearly inthno is hallucinating, making things up or not properly informed. yes they succeeded with the IRENe phase one trial....and proceeded to phase 2. The phase 2 trial is well underway. a quick check of FDA trials, shows that. So , please those reading things on this or any other site, be careful what you read.  Not sure why inthno would post such conclusive information, and point to ...more  
Comment by inthno on Nov 26, 2024 1:53pm
It's all you are getting from me consciousness, which was not related to pelareorep or retifanlimab. One patient with Grade 5 event, which was attributed to disease progression.   Conclusion   The combination of pelareorep and retifanlimab in patients with mTNBC did not show significant anti-tumor activity. One patient had a partial response. Tumor tissue, stool and ...more  
Comment by Noteable on Nov 26, 2024 2:03pm
As presented at SABC 2021 : The [Irene] study has enrolled 5 patients. There have not been any safety concerns noted so far with the combination. The study will continue to enroll patients at Rutgers Cancer Institute of New Jersey and Ohio State University Comprehensive Cancer Center. https://oncolyticsbiotech.com/wp-content/uploads/2022/12/IRENE-study-SABCS-ppt-slide-FINAL.pdf https ...more  
Comment by jh1970 on Nov 26, 2024 5:54pm
Results Fifteen patients were enrolled in the study (100% women). Median age was 58.6yrs. (66% White, 20% African American, 13% Asian). One patient withdrew from study due to grade 3 fatigue after C1D15. This patient was not included in the efficacy assessment. Of the fourteen evaluable patients in stage 1 of the study, one patient had partial response (ORR of 7.1%). Duration of response in this ...more  
Comment by Noteable on Nov 26, 2024 6:58pm
If the Irene Sstudy was terminated at the end of Phase 1, as you claim, how is it then that the principal investigator is reporting on Phase 2 TNBC results at SABC 2024 on December 11, 2024?
Comment by inthno on Nov 26, 2024 7:12pm
The article does say terminated at the end of stage 1 not phase 1  so there must be a difference. Otherwise we shall know in December whether the trial was a success or not
Comment by inthno on Nov 26, 2024 6:21pm
Well CF, someone else posted the same on Irene, I am guessing u might as well attack them too for post real relevant information unlike u who makes conjecture and tells people that Matt exercised 350k options. You should really check before doing that as it appears u k ow a lot less than what you want people.to believe. At least note posts real stuff even it not at all relatable.and.redundant.
Comment by Buckhenry on Nov 26, 2024 6:26pm
But CF is a college professor... he wants us to know how impotent he is....
Comment by canadafan on Nov 26, 2024 7:43pm
Too bad Bucky never made it past grade 8.
Comment by Buckhenry on Nov 26, 2024 8:47pm
You are an egotistical nut canuckcluck...  no one is important on here including me. I could care less what anyone's resumes says. You goofball pumpers  are taking this to a lower level here... get over yourself. No one cares. 
Comment by inthno on Nov 26, 2024 8:57pm
Wow notable and cf actually think they are better than anyone else even when presented with actual results they don't believe.the paper it's printed on. Anyone who brags as much as cf has an insecurity problem so gotta let everyone know what they have done to try and prove themselves. How many predictions have you made that have been correct or posting misinformation. Why people give u so ...more  
Comment by Buckhenry on Nov 26, 2024 9:14pm
Canuckcluck  if you were even remotely edumacated... you would know not to judge people...  maybe in your circle you are somebody... but here your just another pumper. You know nothing about me or other people here but I'm sure you will conjure a guess and continue to make yourself look impotent. Actually you remind me of the south end of a north bound mule
Comment by Buckhenry on Nov 26, 2024 9:27pm
Yes unnoteable... you have posted this and other nonsense today...  we need to step up and bury the pumpers posts just as they try to do ours. 
Comment by Peladawn on Nov 27, 2024 12:12am
Well Bucky...I gotta give you that one!....If anybody knows about the south end of a northbound mule, it would definitely be you!
Comment by Buckhenry on Nov 27, 2024 10:40am
Yes i consider myself an expert as I got alot of experience dealing with many mules azzwholes on here the last few years. 
Comment by Peladawn on Nov 27, 2024 10:52am
Yeah Bucky, but maybe you should go and wash some of that 'experience' off your face, and then brush your teeth....it's pretty disgusting.
Comment by Buckhenry on Nov 27, 2024 10:55am
Smells like a rose compared to the garbage you pumpers been spewing out...  mine will wash off but yalls never will. 
Comment by venture009 on Nov 27, 2024 11:43am
The ultimate judge is always the market and the current volume and sp is telling us there is not a whole lot of optimism. Over the years we have read all the optimistic rhetoric and the results have always been the same. Nothing of consequence as far as the sp. For years this has been the case. Always the bridesmaid never a bride. This time I believe management is focused on selling but they are ...more  
Comment by Angler101 on Nov 27, 2024 10:36pm
Sorry Bucky...but, I'm afraid all the soap and mouthwash in the world won't get rid of the smell of what you've bin lickin!
Comment by Azzak34 on Nov 28, 2024 7:56am
https://medicalxpress.com/news/2024-11-cancer-treatment-monocytes-boost-cells.html
Comment by 2O2Ovision on Nov 27, 2024 1:25pm
Full Abstracts minus embargoed_FINAL.pdf Hope link works... or as follows.. P1-09-19: IRENE study: Phase 2 study of oncolytic virus pelareorep and PD-1 inhibitor retifanlimab in metastatic triple negative breast cancer Presenting Author(s) and Co-Author(s): Mridula George, Mridula A. George, Nicole O. Williams, Coral Omene, Danielle Tang, Shou-En Lu, Matt Coffey, Thomas Charles Heineman, Shridar ...more  
Comment by inthno on Nov 27, 2024 1:56pm
You must be careful posting this 2020vision as I am sure that the bashing will start soon as no one wants to hear of a possible failed trial with the company. As for CF, this confirms what i reported earlier but of course do not expect an aplogy from you. Also I was not bashihng the company, just reporting the ofjective facts which of course you did not check into before you started your bashing.
Comment by Buckhenry on Nov 27, 2024 4:28pm
Just curious if stock price still matters?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities